Prognosis and 5-year Follow-up of 213 Cases of StageⅢB Adenocarcinoma Patient of Esophagogastric Junction Treated by Surgery

LI Baozhong; LIU Shiwei; ZHANG Yufen; HE Ming; CHEN Xin; ZHU Hui; XU Xinjian; LI Fei

doi:10.3971/j.issn.1000-8578.2015.10.011

Cancer Research on Prevention and Treatment > 2015 > 42(10): 1001-1004. > DOI: 10.3971/j.issn.1000-8578.2015.10.011

LI Baozhong, LIU Shiwei, ZHANG Yufen, HE Ming, CHEN Xin, ZHU Hui, XU Xinjian, LI Fei. Prognosis and 5-year Follow-up of 213 Cases of StageⅢB Adenocarcinoma Patient of Esophagogastric Junction Treated by Surgery[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 1001-1004. DOI: 10.3971/j.issn.1000-8578.2015.10.011

Citation:

PDF (1503 KB)

Prognosis and 5-year Follow-up of 213 Cases of StageⅢB Adenocarcinoma Patient of Esophagogastric Junction Treated by Surgery

1. Department of Thoracic Surgery, The Fourth Hospital, Hebei Medical University, Shijiazhuang 050011, China; 2. Department of Thoracic Surgery, The First Hospital of Xingtai Medical Institute, Xingtai 054001, China

More Information

Received Date: December 24, 2014
Revised Date: January 22, 2015

Graphical Abstract

Abstract

Abstract

Objective To analyze the therapeutic effect and prognosis-related factors of the patients with stageⅢB adenocarcinoma of esophagogastric junction(AEG) treated by surgery. Methods We analyzed retrospectively the clinicopathologic data of 213 AEG patients treated in the Fourth Hospital of Hebei Medical University from March 2006 to February 2007. A 5-years follow-up was conducted for this cohort of patients. Survival analysis was performed by Kaplan-Meier method and survival rate was obtained by life table method. Multivariate analysis was applied using Cox proportional hazard model. Results Radical surgery was performed in 207 patients; enlargement surgery was done in 3 patients, whereas the palliative operation was taken in 3 cases. The overall 1-, 3- and 5-year survival rates of this cohort were 80.0%, 46.0% and 32.0% respectively. These factors as follows were shown to be related to patients' survival by univariate analysis: gender, surgical type, surgical margin and adjuvant chemotherapy. Multivariate analysis demonstrated that gender(P=0.016), surgical type(P=0.025), surgical margin (P=0.002) and adjuvant chemotherapy(P=0.001)were regarded as independent prognostic factors. Conclusion The prognosis of stageⅢB AEG patients remains poor. Gender, surgical type, surgical margin and adjuvant chemotherapy are regarded as independent prognostic factors. Comprehensive therapy remains vital to enhance the treatment efficacy.
- Adenocarcinoma of esophagogastric junction(AEG),
- Surgery,
- Prognosis,
- Survival analysis

FullText(HTML)

References (12)

References

[1]	Davies AR, Gossage JA, Zylstra J, et al. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for a denocarcinoma of the esophagus and esophagogastric junction[J]. J Clin Oncol, 2014, 32(27): 2983-90.
[2]	Hosokawa Y, Kinoshita T, Konishi M, et al. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert’s classification after radical resection[J]. Anticancer Res, 2014, 34(8): 43 91-7.
[3]	Chen ZF, Chen WQ, Zhang SW, et al. To Pay Attention on the Study of Diagnostic Standard and Epidemiology of Esophageal Adenocarinoma and Gastric Cardia Adenocarcinoma[J]. Zhongguo Zhong Liu, 2010, 19(8): 518-21. [陈志峰, 陈万青, 张思维, 等. 重视对食管腺癌、贲门腺癌诊断标准及流行病学的研究[J] 中国肿瘤, 2010, 19(8): 518-21.]
[4]	Zheng B, Chen YB, Hu W, et al. Trend analysis for clinical characteristics and prognosis of adenocarcinoma of cardia[J]. Ai Zheng, 2010, 29(1): 94-7. [郑斌, 陈映波, 胡祎, 等. 贲门癌患者临床病理特点及预后变化趋势分析[J]. 癌症, 2010, 29(1): 94-7.]
[5]	Chen ZF, Song GH, Hou J, et al. Esophageal and gastric cancer incidence trend in Cixian from 1988 to 2007[J]. Zhongguo Zhong Liu, 2011, 38(14): 839-42. [陈志峰, 宋国慧, 侯浚, 等. 1988至 20 07年磁县食管癌和胃癌发病趋势分析[J]. 中国肿瘤, 2011, 38 (14): 839-42.]
[6]	Zhao CY, Zhang XH, Xue LY, et al. Analysis of the changing trends of frequency and localization of gastric cancers arising from different sites of the stomach in population of the high incidence area of esophageal and gastric cancers in Hebei province[J]. Zhonghua Zhong Liu Za Zhi, 2008, 30(11): 817-20. [赵燕晨, 张祥宏, 薛丽英, 等. 河北省食管癌和胃癌高发区居民胃癌发生部位的变化趋势[J]. 中华肿瘤杂志, 2008, 30(11): 817-20.]
[7]	Wang Y, Wang JT, Liu YL, et al. Analysis of clinical data of inpatients with gastric carcinoma in Peking University People's Hospital over the past ten years[J]. Zhongguo Xian Dai Yi Xue Za Zhi, 2011, 21(5): 596-603. [王妍, 王晶桐, 刘玉兰, 等. 北京大学人民医院10年住院患者胃癌临床资料分析[J]. 中国现代医学杂志, 2011, 21(5): 596-603.]
[8]	Ding XW, Wang XiN, Xue Q, et al. Clinicomathological characteristics of gastric cardia cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2010, 17(10): 770-2. [丁学伟, 王晓娜, 薛强, 等. 贲门癌的临床病理特征分析[J]. 中华肿瘤防治杂志, 2010, 17 (10): 770-2.]
[9]	Yang ZX, Wang L, Wang YD, et al. Comparison of FOLFOX 4 regimen and FLP regimen as adjuvant chemotherapy for esophagogastric junction carcinoma and distal gastric carcinoma[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2011, 16(8): 71 9-24. [杨子鑫, 王龙, 王玉栋, 等. FOLFOX 4与FLP方案用于食管胃结合部癌和远端胃癌辅助化疗的比较[J]. 临床肿瘤学杂志, 2011, 16(8): 719-24.]
[10]	Liu SZ, Zeng FC, Xue Y, et al. The surgical treatment experience of 136 esophageal and gastric cardia carcinoma patients with elderly age[J]. Sichuan Yi Xue, 2011, 32(12): 1864-6. [刘胜中, 曾富春, 薛洋, 等. 136例高龄食管癌、贲门癌患者的外科手术治疗体会[J]. 四川医学, 2011, 32 (12): 1864-6.]
[11]	Lin T, Lan B, Xie CF, et al. Indication of different incision of patients with carida cancer[J]. Shi Yong Yi Xue Za Zhi, 2011, 27 (14): 2623-5. [林艇, 蓝斌, 谢春发, 等. 胃底贲门癌根治术不同手术入路的适应证探讨[J]. 实用医学杂志, 2011, 27(14): 26 23-5.]
[12]	Sun C, Wang Y, Yao HS, et al. Allogeneic blood transfusion and the prognosis of gastric cancer patients: Systematic review and meta-analysis[J]. Int J Surg, 2015, 13: 102-10.

[1]	HU Zhen, LI Shengjin. Survival and Prognosis of Primary Mediastinal and Pulmonary Sarcoma Based on SEER Database[J]. Cancer Research on Prevention and Treatment, 2023, 50(11): 1091-1096. DOI: 10.3971/j.issn.1000-8578.2023.23.0419
[2]	ZHOU Sicheng, WU Haifeng, PAN Yuting, YUN Hong, CAO Shaomu, NIE Hongxia, XING Wei, LIANG Jianwei. Clinicopathological Characteristics and Survival Prognosis Analysis of 102 Rectal Cancer Patients with Lateral Pelvic Lymph Node Metastases[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 33-37. DOI: 10.3971/j.issn.1000-8578.2023.22.0655
[3]	WANG Yan, CAO Yu, YIN Jinhuan, LIU Junfeng. Correlation of Prognostic Nutritional Index with Overall Survival of Postoperative Patients with Thymoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 140-144. DOI: 10.3971/j.issn.1000-8578.2021.20.0651
[4]	CHEN Mengxue, SANG Nan, GE Xian, CHEN Jiaxi, HUANG Qian, LI Xueliang. Risk Factors of Non-curative Resection in Superficial Esophageal Cancer After Endoscopic Submucosal Dissection and Long-term Survival Analysis[J]. Cancer Research on Prevention and Treatment, 2020, 47(4): 278-282. DOI: 10.3971/j.issn.1000-8578.2020.19.0691
[5]	LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
[6]	GAO Rupan, ZOU Shanhua, LI Feng, WANG Weiguang, CHENG Zhixiang, YUAN Ling, CHENG Yunfeng. Clinical Manifestation and Survival Analysis with Myeloid Sarcoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(06): 538-540. DOI: 10.3971/j.issn.1000-8578.2013.06.008
[7]	SHEN Ling, ZHU Hai-chao, HUANG Jian-feng, CHU Jian-jun. Survival Analysis of 108 Cases with Advanced Primary Liver Cancer Treated by Transcatheter Arterial Chemoembolization[J]. Cancer Research on Prevention and Treatment, 2011, 38(10): 1163-1166. DOI: 10.3971/j.issn.1000-8578.2011.10.018
[8]	WANG Yu-xiang, ZHU Shu-chai, QIU Rong, SU Jing-wei, SHEN Wen-bin. Prognosis of T4 Esophageal Carcinoma with Three-dimensional Conformal Radiotherapy[J]. Cancer Research on Prevention and Treatment, 2011, 38(06): 690-694. DOI: 10.3971/j.issn.1000-8578.2011.06.023
[9]	SUN Fa-lin, BU Shi-chong, MA Ke, LI Qing-yun. Retrospectively Analysis of Prognostic Correlative Factors of Aryngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(05): 405-408. DOI: 10.3971/j.issn.1000-8578.2009.05.012
[10]	SUN Xi-bin, DUAN Weng-jie, WANG Jing-p ing, et al, . Analysis of Cox Model for Clinical Pathology Factors with Prognosis in Colorecatal Cancer[J]. Cancer Research on Prevention and Treatment, 2001, 28(05): 383-384. DOI: 10.3971/j.issn.1000-8578.970

Cited By

Get Citation

PDF

XML

Article views (1429) PDF downloads (525)

Turn off MathJax

Article Contents

Abstract

References

Prognosis and 5-year Follow-up of 213 Cases of StageⅢB Adenocarcinoma Patient of Esophagogastric Junction Treated by Surgery

Abstract

References

Related Articles

Catalog

Download Center

Links

Contact Us

Prognosis and 5-year Follow-up of 213 Cases of StageⅢB Adenocarcinoma Patient of Esophagogastric Junction Treated by Surgery

Abstract

References

Related Articles

Catalog

Download Center

Links

Contact Us

Export File

Citation

Format

Content